Home » Authors » Katie Pfaff

Katie Pfaff

katie.pfaff@clarivate.com

Articles

ARTICLES

Nuvolo's new platform takes aim at connected medical device security

May 7, 2018

Abbott wins FDA approval for Advisor HD Mapping Catheter

May 4, 2018

Researchers nanoengineer hydrogel to stop bleeding

May 3, 2018

Med-El receives FDA nod for conductive hearing loss system

May 2, 2018

Inari Medical shares positive results from FLARE study of Flowtriever PE device

May 1, 2018

Feinstein Institute hopes to decode vagus nerve signals

April 30, 2018

Researchers to make 3-D bioprinting accessible

April 27, 2018

Idx patents AI-based tech that detects cardiovascular risk through retinal image

April 26, 2018

Mauna Kea's Cellvizio aids in recognition of human 'organ'

April 24, 2018

Varian wins 510(k) for Calypso transponder for tumor tracking

April 23, 2018

View All Articles by Katie Pfaff

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.